Tag: protein

VANCOUVER, B.C., September 24, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”) announces that it has completed the first tranche of its previously announced $5,000,000 non-brokered private placement (the “Offering”), as described in its news release dated September 14, 2021, pursuant to which it has issued an aggregate of 6,028,750 units (each, a “Unit”) at a price of $0.16 per Unit for aggregate gross proceeds of $964,600 (the “Initial Tranche”). Each Unit consists of one common share in the capital of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder thereof to acquire one additional Share (each, a “Warrant Share”) at a price of $0.30 per Warrant Share for a period of 2 years from the closing date.

The proceeds from the Offering are expected to be used for general working capital as well as to further fund the construction of the Company’s Surrey facility.

The Company paid cash finder’s fees of an aggregate of $9,280 and issued an aggregate of 58,000 Warrants (each, a “Finder’s Warrant”) to certain eligible finder’s in connection with the closing of the Initial Tranche. Each Finder’s Warrant is exercisable into one Share at a price of $0.30 per Share for a period of two years from the closing date. 

All securities issued in connection with the closing of the Initial Tranche are subject to a statutory hold period expiring on January 24, 2022.

None of the securities to be issued in connection with the Offering will be or have been registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release is being issued pursuant to Rule 135c of the 1933 Act and shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of the securities, in any state where such offer, solicitation or sale would be unlawful.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based agricultural technology company that will enable millions to rethink their food choices while helping people do the world a world of good. By offering sustainably grown plant based food options that are nutritious and delicious, we’re helping this kind of diet become the norm.

Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

On behalf of the Board of Directors 

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information 

For more information, please contact: 

Connor Yuen Chief
Executive Officer

For further information: 

Investor Relations or Media enquiries:

[email protected]
(403) 589-7992

Forward-Looking Information 

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated use of proceeds of the Initial Tranche by the Company and Pontus’ ability to revolutionize the plant based sector and enable millions to rethink their food choices. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive TSX Venture Exchange approval for the closing of the remainder of the Offering, Pontus’ inability to close further tranches of the Offering, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey Facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

VANCOUVER, B.C., September 14, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”) is pleased to announce a non-brokered private placement consisting of up to a maximum of 31,250,000 units of the Company (each, a “Unit”) at a subscription price of $0.16 per Unit for gross proceeds up to a maximum of $5,000,000 (the “Offering”). Each Unit will consist of one common share in the capital of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder thereof to acquire one additional share (each, a “Warrant Share”) at a price of $0.30 per Warrant Share for a period of 2 years from the date of issuance. The Offering may close in one for more tranches.

The proceeds from the Offering are expected to be used for general working capital purposes. Finder’s fees may be payable in connection with the Offering in accordance with the policies of the TSX Venture Exchange (the “Exchange”).

All securities issued in connection with the Offering will be subject to a statutory hold period expiring four months and one day after closing of the Offering. Completion of the Offering is subject to a number of conditions, including, without limitation, receipt of all regulatory approvals, including approval of the Exchange.

None of the securities to be issued in connection with the Offering will be or have been registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release is being issued pursuant to Rule 135c of the 1933 Act and shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of the securities, in any state where such offer, solicitation or sale would be unlawful.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based agricultural technology company that will enable millions to rethink their food choices while helping people do the world a world of good. By offering sustainably grown plant based food options that are nutritious and delicious, we’re helping this kind of diet become the norm.

Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

On behalf of the Board of Directors 

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information 

For more information, please contact: 

Connor Yuen Chief
Executive Officer

For further information: 

Investor Relations or Media enquiries:

[email protected]
(403) 589-7992

Forward-Looking Information 

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated use of proceeds of the Offering by the Company and Pontus’ ability to revolutionize the plant based sector and enable millions to rethink their food choices. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive Exchange approval for the Offering, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey Facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

VANCOUVER, BC, Sept. 9, 2021  /CNW/ – Pontus Protein Ltd. (TSXV: HULK) (OTCQB: HLKKF) (FSE: 8YC) (“Pontus” or the “Company“) is pleased with the progress on the development of its first commercial production facility. The 20,570 sq. ft. production facility is located in Surrey, British Columbia (the “Surrey Facility“).

“After years of planning and testing in our Victoria, B.C., test facility, I am very pleased to see the progress with the tenant improvements for the facility construction. I can see the floor plan coming to life,” said Steve McArthur, Chief Technology Officer of Pontus, who has also provided a video of the progress here.

“Our entire team, from EllisDon, ICE Construction and all their subtrades, engineering and architectural consultants have been a pleasure to work with. We’ve been moving as quickly and efficiently as possible, while staying on budget, and having fun while we do it.”

Pontus received their work permit to begin tenant improvements from the City of Surrey in May 2021. Since then, the Company has secured EllisDon as its owner’s representative, and ICE Construction as the general contractor. The Company has seen rapid progress in developing the shell of the building into a biosecure facility using novel technology to sustainably grow the rapidly growing and highly nutritious water lentil species.

The internal walls and flooring are 95% complete. These are targeted to be complete by the end of next week. At that time, installation of the fish farm and shelving will begin.

The laboratory was completed mid-summer, as projected, and is currently awaiting electricity to be installed which is planned within the next two weeks. At that point, Pontus can start its initial production phase that will enable consumer acceptance testing to be completed, to finalize packaging development, and begin initial product sales.

Equipment for the facility has arrived and is in storage, including the custom-designed LED lights, shelving, drum filter and UV filter for the fish farm. Due to COVID, some items were predicted to take a longer lead time. For example, the air handling units in the HVAC moved to 30 weeks. The team has worked collaboratively to source new units that can be delivered in 10 weeks and re-engineered the design for these specific units.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based agricultural technology company that will enable millions to rethink their food choices while helping people do the world a world of good. By offering sustainably grown plant based food options that are nutritious and delicious, we’re helping this kind of diet become the norm.

Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

To learn more, please visit pontuswaterlentils.com.

*https://www.infood.net/visitor/collection/75?portion_size=100

On behalf of the Board of Directors

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information

For more information, please contact:

Connor Yuen Chief
Executive Officer

Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated timelines for the completion of the Surrey Facility’s various leasehold improvements and Pontus’ ability to revolutionize the plant based sector and enable millions to rethink their food choices. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey Facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

SOURCE Pontus Protein Ltd.

For further information: Investor Relations or Media enquiries: [email protected], (403) 589-7992

VANCOUVER, B.C., July 6, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company“), is pleased to announce that its US-based OTC Markets listing under the ticker symbol “HLKKF” has received approval from the Depository Trust Company (“DTC“).  

“We are very excited to receive DTC eligibility, granting us the ability to significantly reduce costs in trading shares, which in turn opens up the US market to all retail investors, who follow our vision for sustainability and reinventing agriculture,” said Connor Yuen, CEO of Pontus. “We believe this move will lead to greater liquidity, providing current and prospective US investors further opportunities to participate in Pontus’ growth. This is a timely development, as Pontus looks to complete its facility and begin production.“ 

DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly-traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered to be DTC eligible. DTC eligibility is required to create a seamless electronic trading process and thereby enhance the liquidity of the Company’s shares. 

Results of Annual General Meeting 

Pontus is pleased to report the results of its Annual General Meeting, held on June 30, 2021, in Vancouver, B.C. A total of 16,650,484 common shares were voted at the meeting representing 25.031% of the votes attached to all outstanding shares. All resolutions were passed by shareholders. 

Shareholders voted in favour to set the number of directors at five and for the election of all director nominees for the ensuing year. 

VANCOUVER, B.C., June 17, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”) is pleased to announce that it has selected ICE Constructors Ltd. (“ICE Constructors”) as the General Contractor and EllisDon Construction Svc. Inc. (“EllisDon”) as the Owners Representative to complete Pontus’ Surrey, British Columbia farm facility (the “Facility”). Both collaborative parties have already initiated work on the construction of the Facility.

Pontus has divided the development of the Facility into Three Phases. Phase One was the lab build, which is now complete, and production is set to start in approximately a week with the arrival of Pontus’ water lentils. Phase Two includes the full production capability, and has been initiated by EllisDon and ICE Constructors. The final phase, Phase Three, is the added value phase, and includes the installation of the Facility’s production kitchens.

About ICE Constructors 

ICE Construction, part of the ICE Group of Companies, founded in 2004, has been executing the base build, design-build and tenant improvements of various British Columbia business, including the BC Liquor Branch Head office in Burnaby. ICE Construction also has experience in vertical farming as well as agritech, working with various cannabis producers helping design their manufacturing facilities.

ICE was selected for its experience in other local facility builds in the region and support/recommendations the Company received from the skilled trades keen to work on this project.

Sonny Sangha, President of ICE Group of Companies, stated, “We are excited to work on this project. Projects like this do not come along every day, and I believe we can both learn from each other. The Pontus team is motivated to get this project complete.”

About EllisDon 

EllisDon is a global project management and construction services company founded in 1951, which will act on behalf of Pontus to oversee the construction and ensure the build meets the design and standards set out by Pontus. EllisDon brings similar experience to the construction of Pontus’ Facility, and has experience in Agri manufacturing facilities including Cavendish Farms.

EllisDon was selected to represent Pontus and ensure the build meets the original design and high standards set out by Pontus. EllisDon’s experience working in sensitive environments, such as clean hospital environments, lends its highest standards as the Facility is a food facility and must practice the highest biosecure standards. Also, EllisDon’s commitment to sustainability is aligned with Pontus’ core values.

Jonathan Motyka, Senior Project Manager from EllisDon, added, “Yes, we’re excited too, to be able to work with an up-and-coming company to deliver a unique and, dare I say it, cool facility.”

About Pontus Protein Ltd. 

Pontus Protein Ltd. is a Vancouver, B.C. based technology company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for nutrition rich plant based food products, functional foods and nutraceuticals to support the movement transitioning the world from meat based to plant based proteins.

To learn more, please visit pontuswaterlentils.com.

*https://www.infood.net/visitor/collection/75?portion_size=100 

On behalf of the Board of Directors  

“Connor Yuen”

Connor Yuen, CEO 
Pontus Protein Ltd.

Contact Information 

For more information, please contact:

Connor Yuen 
Chief Executive Officer

For further information: 

Investor Relations or Media enquiries:

[email protected] 
(403) 589-7992 

Forward-Looking Information 

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to Pontus’ ability to revolutionize the plant based sector as well as the anticipated delivery of Pontus’ water lentils and production start date. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete the construction of the Facility or specific phase thereof, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

VANCOUVER, B.C., June 9, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”), is pleased to announce that it has filed an international patent application through the Patent Coordination Treaty with the World Intellectual Property Organization for Pontus’ proprietary Harvesting Automated Robotic Vehicle or “HARV” for short. HARV is a vertical farm rack system and automated plant tending and harvesting robot designed to work along side and assist Pontus’ Closed Environment Vertical Aquaponics System or CEVAS system.

Pontus’ initial crop, water lentils, is the fastest growing leafed plant.* Pontus’ CEVAS helps accelerate the growth of Pontus’ water lentils, requiring the plant to be harvested every 24 hours. Pontus developed the HARV technology to allow the crop to be automatically harvested daily. In addition, due to its low profile, Harv will enable Pontus to stack nine levels of vertical farming at its Surrey, British Columbia production facility.

VANCOUVER, B.C., June 1, 2021. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”), is pleased to announce that its common shares have commenced trading on the OTCQB Venture Marketplace (“OTCQB”) in the United States under the symbol “HLKKF”.

The OTCQB is a US trading platform that is operated by the OTC Markets Group in New York providing access to the significant US investor base. Pontus’ OTCQB information can be found on the OTC Markets website: https://www.otcmarkets.com/stock/HLKKF/overview.

Connor Yuen, CEO of Pontus, stated: “Our listing in the US on the OTCQB allows us to offer our current and future US investors easier access to buy and trade Pontus shares in the very active plant protein market. It will also increase visibility and access to the highly active agritech market in the US. This is an excellent opportunity to expand our investor base beyond Canada and Europe.”

Pontus’ common shares are now available through the major brokers in the US, including TD Ameritrade, Fidelity, Tradestation, Interactive Brokers, E-Trade, Ally Invest and Charles Schwab.

With the commencement of trading on the OTCQB, Pontus will now be available for trading on three marketplaces around the world including the Frankfurt Stock Exchange, the world’s third largest exchange, and the Toronto Stock Venture Exchange.

OTCQB trading is non-dilutive to existing Pontus shareholders, as no new common shares are being issued to enable trading on the OTCQB.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

To learn more, please visit pontuswaterlentils.com.

*https://www.infood.net/visitor/collection/75?portion_size=100

On behalf of the Board of Directors

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information

For more information, please contact:

Connor Yuen
Chief Executive Officer

For further information:

Investor Relations or Media enquiries:

[email protected]
(403) 589-7992

Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, Pontus’ ability to revolutionize the plant based sector. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey-based production facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

VANCOUVER, B.C., May 20, 2021. Pontus Protein Ltd. (TSXV: HULK, FSE: 8YC) (“Pontus” or the “Company”), is pleased to announce that, further to its prior news releases dated May 18, 2021, March 31, 2021, February 24, 2021 and February 3, 2021, the City of Surrey has awarded Pontus its building permit for the 20,570 sq ft production facility in Surrey, British Columbia (the “Surrey Facility”). 

Connor Yuen, Pontus’ CEO stated, “This is a significant milestone for Pontus, enabling us to develop the facility using proprietary technology to produce a game changing superfood. The design and process for approvals will act as a template and model for future facilities.” 

Tenant improvements will commence with phase 1, the test facility, and then continue with phase 2, the commercial outfitting. Due to the increased size of the Surrey Facility, Pontus is forecasting an annual production capacity of up to 11.0 metric tonnes, a 72% increase to its originally stated volume of 6.4 metric tonnes of annualized product. 

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

To learn more, please visit pontuswaterlentils.com.

*https://www.infood.net/visitor/collection/75?portion_size=100

On behalf of the Board of Directors

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information

For more information, please contact:

Connor Yuen
Chief Executive Officer

For further information:

Investor Relations or Media enquiries:

[email protected]
(403) 589-7992

Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated completion of the Surrey Facility, and any anticipated production benefits therefrom including, but not limited to, estimated production yields or outputs of Pontus’ water lentils, and Pontus’ ability to revolutionize the plant based sector. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency, the inability to complete the Surrey facility’s leasehold improvements, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

VANCOUVER, B.C., May 18, 2021. Pontus Protein Ltd. (TSXV: HULK, FSE: 8YC) (“Pontus” or the “Company”), is pleased to announce that, pursuant to its news releases dated March 31, 2021, February 24, 2021 and February 3, 2021, Pontus is on track to complete its phase 1 of production, laboratory infrastructure (the “Lab”) construction by mid-June, at its Surrey, British Columbia production facility (the “Surrey Facility”). The Lab will replace the current production capacity from Pontus’ first farm in Victoria, B.C.

“We are very pleased to bring the first part of our production capabilities online. The Lab has three immediate benefits: firstly, allowing increased production for additional scientific testing as we work towards our nutraceutical regulations in the U.S. and Canada; secondly, allowing batch protein powder production enabling third-party manufacturers to initiate product development; and lastly, the Lab will allow us to further test and refine our new technologies, such as HARV (“Harvesting Automated Robotic Vehicle”),” said Steve McArthur, Pontus’ Chief Technology Officer.

Prior to securing the prebuilt 20,570 sq ft Surrey Facility, Pontus forecasted its annual production capacity at 6.4 metric tonnes of annualized product based on building a 10,000 sq ft facility. The additional space of the Surrey Facility has enabled Pontus to add the research and development Lab space and increase its overall production capacity. Based on detailed analysis, the Company is now projecting an increased production of up to 11.0 metric tonnes of annualized product, a 72% increase in output from previously stated numbers.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.

To learn more, please visit pontuswaterlentils.com.

*https://www.infood.net/visitor/collection/75?portion_size=100

On behalf of the Board of Directors

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information

For more information, please contact:

Connor Yuen
Chief Executive Officer

For further information:

Investor Relations or Media enquiries:

[email protected]
(403) 589-7992

Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated completion of the Surrey Facility, including the Lab construction, and any anticipated production benefits therefrom including, but not limited to, estimated production yields or outputs of Pontus’ water lentils, and Pontus’ ability to revolutionize the plant based sector. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the City of Surrey for its proposed leasehold improvements at its Surrey Facility or from the Canadian Food Inspection Agency, the inability to complete the Surrey facility’s leasehold improvements, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

VANCOUVER, B.C., April 15, 2021. Pontus Protein Ltd., the sustainable food technology company (TSXV: HULK, FSE: 8YC) (“Pontus” or the “Company”), is pleased to announce the appointment of leading international aquaponics expert, Mr. Marc Laberge to its Board of Advisors effective immediately. In connection with the appointment, the company has granted Mr. Laberge stock options to purchase 50,000 shares, which are exercisable at $0.40 per share for a period of two years. The options shall vest on the three month anniversary and are subject to TSXV Exchange approval.

Mr. Laberge is one of the world’s pioneers in commercial aquaponics, having advised NASA (National Aeronautics and Space Administration, USA) on food in space and designed a 600-tonne aquaponics facility in China. He approached aquaponics as a fish biologist, with over 34 years of expertise in recirculating technology, and has been an aquatic consultant since 1991, through ML Aquaponics Inc. Mr. Laberge helped design the fish section of the aquaponics that will seek to drive Pontus’ commercial farming facility in Surrey, British Columbia.

Mr. Laberge commented, “I am delighted to be joining the Pontus Board of Advisors. I have enjoyed collaborating with Steve McArthur over the years and am excited to advise on Pontus’ Controlled Environment Vertical Aquaponics System or CEVAS for short. It is one of the most advanced aquaponic solutions globally.”

Speaking about the new appointment, Steve McArthur, Chief Technology Officer of Pontus, said: “Marc brings years of aquaponics experience to Pontus and strategic depth to our team. Having Marc on our Board of Advisors will facilitate scientific and engineering collaborations. This will enable us to continuously improve our closed vertical aquaponics system, especially as we optimize the automation and farm management robotics.”

Warrants Acceleration Clarification

For clarification purposes, the Company wishes to confirm to shareholders of the Company that it has not exercised its right to accelerate the expiry date of the warrants subject to the terms and conditions of the Warrant Indenture dated January 25, 2021. Any suggestion to the contrary was not under direction of the Company. Any shareholders who have not exercised should be aware that there is no applicable acceleration provisions and that unless they want to, they do not have to exercise the warrants within the thirty day period. If anyone has exercised as a result but have not received the DRS, or who exercised, but now have the DRS, they should contact [email protected] In the event the Company does elect to exercise the acceleration provisions, the Company will notify its shareholders by way of a news release in accordance with the provisions of the Warrant Indenture.

For more information on the warrants and the Warrant Indenture, please see the Company’s news releases dated August 14, 2020, November 27, 2020, December 2, 2020, December 11, 2020 and January 26, 2021 filed on SEDAR. A copy of the Warrant Indenture is also available under Pontus’ profile on SEDAR.

About Pontus Protein Ltd.

Pontus Protein Ltd. is a Vancouver, B.C. based company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS™) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant-based sector as the entire sector is currently based on two main protein sources: soy and pea. Lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims at being the base protein for plant based food products, which will lead this movement that has begun in the world transitioning from meat based to plant based protein.

To learn more, please visit pontuswaterlentils.com.

*https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555161/

On behalf of the Board of Directors

“Connor Yuen”

Connor Yuen, CEO
Pontus Protein Ltd.

Contact Information

For more information, please contact:

Connor Yuen
Chief Executive Officer

For further information:

Victoria Bennett
[email protected]
(403) 589-7992

Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, Pontus’ ability to revolutionize the plant based sector. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.